Literature DB >> 21344068

Drug-related Sleep Stage Changes: Functional Significance and Clinical Relevance.

Timothy Roehrs1, Thomas Roth.   

Abstract

Entities:  

Year:  2010        PMID： 21344068      PMCID： PMC3041980          DOI： 10.1016/j.jsmc.2010.08.002

Source DB:  PubMed          Journal:  Sleep Med Clin        ISSN： 1556-407X


× No keyword cloud information.
  86 in total

1.  The GABAA agonist THIP produces slow wave sleep and reduces spindling activity in NREM sleep in humans.

Authors:  J Faulhaber; A Steiger; M Lancel
Journal:  Psychopharmacology (Berl)       Date:  1997-04       Impact factor: 4.530

2.  Beta/Gamma EEG activity in patients with primary and secondary insomnia and good sleeper controls.

Authors:  M L Perlis; M T Smith; P J Andrews; H Orff; D E Giles
Journal:  Sleep       Date:  2001-02-01       Impact factor: 5.849

3.  Response to CPAP and UPPP in apnea.

Authors:  F J Zorick; T Roehrs; W Conway; G Potts; T Roth
Journal:  Henry Ford Hosp Med J       Date:  1990

4.  Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study.

Authors:  C Brodeur; J Montplaisir; R Godbout; R Marinier
Journal:  Neurology       Date:  1988-12       Impact factor: 9.910

5.  EEG spectral analysis in primary insomnia: NREM period effects and sex differences.

Authors:  Daniel J Buysse; Anne Germain; Martica L Hall; Douglas E Moul; Eric A Nofzinger; Amy Begley; Cindy L Ehlers; Wesley Thompson; David J Kupfer
Journal:  Sleep       Date:  2008-12       Impact factor: 5.849

6.  The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study.

Authors:  L Scrima; P G Hartman; F H Johnson; E E Thomas; F C Hiller
Journal:  Sleep       Date:  1990-12       Impact factor: 5.849

7.  Effects of ritanserin on sleep disturbances of dysthymic patients.

Authors:  T Paiva; F Arriaga; A Wauquier; E Lara; R Largo; J N Leitao
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

8.  Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors.

Authors:  A L Sharpley; J M Elliott; M J Attenburrow; P J Cowen
Journal:  Neuropharmacology       Date:  1994 Mar-Apr       Impact factor: 5.250

9.  Effect of short-term treatment with gaboxadol on sleep maintenance and initiation in patients with primary insomnia.

Authors:  Steve Deacon; Luc Staner; Corinne Staner; Annelies Legters; Henrik Loft; Jonas Lundahl
Journal:  Sleep       Date:  2007-03       Impact factor: 5.849

Review 10.  The REM sleep-memory consolidation hypothesis.

Authors:  J M Siegel
Journal:  Science       Date:  2001-11-02       Impact factor: 47.728
View more
  13 in total

Review 1.  Drug-induced sleep: theoretical and practical considerations.

Authors:  Jeffrey M Ellenbogen; Edward F Pace-Schott
Journal:  Pflugers Arch       Date:  2011-09-28       Impact factor: 3.657

Review 2.  Delirium Management in the ICU.

Authors:  Michael E Reznik; Arjen J C Slooter
Journal:  Curr Treat Options Neurol       Date:  2019-11-14       Impact factor: 3.598

3.  Brain age from the electroencephalogram of sleep.

Authors:  Haoqi Sun; Luis Paixao; Jefferson T Oliva; Balaji Goparaju; Diego Z Carvalho; Kicky G van Leeuwen; Oluwaseun Akeju; Robert J Thomas; Sydney S Cash; Matt T Bianchi; M Brandon Westover
Journal:  Neurobiol Aging       Date:  2018-10-19       Impact factor: 4.673

4.  Insomnia, hypnotic use, and health-related quality of life in a nationally representative sample.

Authors:  Julieta Scalo; Pooja Desai; Karen Rascati
Journal:  Qual Life Res       Date:  2014-11-29       Impact factor: 4.147

5.  Quality measures for the care of patients with insomnia.

Authors:  Jack D Edinger; Daniel J Buysse; Ludmila Deriy; Anne Germain; Daniel S Lewin; Jason C Ong; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2015-03-15       Impact factor: 4.062

6.  Static postural stability and neuropsychological performance after awakening from REM and NREM sleep in patients with chronic insomnia: a randomized, crossover, overnight polysomnography study.

Authors:  Wei-Chih Yeh; Yao-Chung Chuang; Chen-Wen Yen; Ming-Chung Liu; Meng-Ni Wu; Li-Min Liou; Cheng-Fang Hsieh; Ching-Fang Chien; Chung-Yao Hsu
Journal:  J Clin Sleep Med       Date:  2022-08-01       Impact factor: 4.324

7.  Insomnia as a path to alcoholism: tolerance development and dose escalation.

Authors:  Timothy Roehrs; Thomas Roth
Journal:  Sleep       Date:  2018-08-01       Impact factor: 5.849

8.  Electroencephalographic power spectral density profile of the orexin receptor antagonist suvorexant in patients with primary insomnia and healthy subjects.

Authors:  Junshui Ma; Vladimir Svetnik; Ellen Snyder; Christopher Lines; Thomas Roth; W Joseph Herring
Journal:  Sleep       Date:  2014-10-01       Impact factor: 5.849

9.  The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action.

Authors:  Daniela Dudysová; Karolina Janků; Michal Šmotek; Elizaveta Saifutdinova; Jana Kopřivová; Jitka Bušková; Bryce Anthony Mander; Martin Brunovský; Peter Zach; Jakub Korčák; Veronika Andrashko; Michaela Viktorinová; Filip Tylš; Anna Bravermanová; Tom Froese; Tomáš Páleníček; Jiří Horáček
Journal:  Front Pharmacol       Date:  2020-12-03       Impact factor: 5.810

10.  Atrial Fibrillation and Objective Sleep Quality by Slow Wave Sleep.

Authors:  Younghoon Kwon; Sneha Gadi; Neil R Shah; Christopher Stout; Jacob N Blackwell; Yeilim Cho; Ryan J Koene; Nishaki Mehta; Sula Mazimba; Andrew E Darby; John D Ferguson; Kenneth C Bilchick
Journal:  J Atr Fibrillation       Date:  2018-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.